Related Experiment Video
Updated: Aug 19, 2026

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
Published on: March 13, 2018
Medical devices; clinical chemistry and clinical toxicology devices; instrumentation for clinical multiplex test
Abstract:
The Food and Drug Administration (FDA) is classifying instrumentation for clinical multiplex test systems into class II (special controls). The special control that will apply to the device is the guidance document entitled "Class II Special Controls Guidance Document: Instrumentation for Clinical Multiplex Test Systems." The agency is classifying the device into class II (special controls) in order to provide a reasonable assurance of safety and effectiveness of the device. Elsewhere in this issue of the Federal Register, FDA is publishing a notice of availability of a guidance document that is the special control for this device.
Related Concept Videos
Automated Microbial Diagnostics
Clinically Relevant Drug Product Specifications: Methods of Establishment
Microbial Biosensors
Drug Products: Biologics, Biosimilars and Interchangeables
